Metraipolis › archive › dc_4eb49282f00a

Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports — Europe PMC PMID:42729427

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42729427
DOI: 10.3389/fimmu.2026.1901390
License (as archived): solo-consultazione
Archived: 2026-10-08T01:27:39.272Z
SHA-256 of the archived text: 63e5f00bfc3c4227ecae393f10fdc1a1cdd72cd714d1316cdd2c629baac41047
Stable URL of this page: https://metraipolis.com/documento/dc_4eb49282f00a

How to cite

Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports — Europe PMC PMID:42729427 — Europe PMC (en), https://europepmc.org/article/MED/42729427 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4eb49282f00a (Metraipolis archive dc_4eb49282f00a, sha256 63e5f00bfc3c4227ecae393f10fdc1a1cdd72cd714d1316cdd2c629baac41047)

BibTeX

@misc{dc4eb49282f00a,
  title = {Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports — Europe PMC PMID:42729427},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42729427},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4eb49282f00a; sha256 63e5f00bfc3c4227ecae393f10fdc1a1cdd72cd714d1316cdd2c629baac41047},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42729427. Agents can read the archived copy with the MCP tool read_document.